Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

PSAPL1 protein levels

SORCS2 · rs73212548

Strength of the evidence

3 / 4

Its strongest genetic-study result is p = 10−158, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 47,745 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.145 lower (95% confidence interval 0.13-0.16); p = 4 × 10−159.

How common The A allele had a frequency of about 33% in the people studied.

Where it sits Chromosome 4, band 4p16.1 — in an intron of SORCS2.

How common each version is

AC
Korean KRGDB
A 61.0% · C 39.0%
Korean Korea4K
A 61.7% · C 38.4%
Korean Korea1K
A 61.9% · C 38.1%
Japanese ToMMo
A 59.0% · C 41.0%
Vietnamese
A 63.9% · C 36.1%
World gnomAD
A 28.4% · C 71.6%
World 1000 Genomes
A 32.8% · C 67.2%
World TOPMed
A 27.4% · C 72.6%

By ancestry gnomAD

East Asian
A 61.5% · C 38.5%
European (non-Finnish)
A 32.6% · C 67.4%
African / African American
A 13.6% · C 86.4%
South Asian
A 38.0% · C 62.1%
Admixed American (Latino)
A 30.9% · C 69.1%
Middle Eastern
A 28.2% · C 71.8%
Finnish
A 34.8% · C 65.2%
Ashkenazi Jewish
A 29.7% · C 70.3%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to PSAPL1 protein levels. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/C One copy of the version the research linked to PSAPL1 protein levels. That is a smaller link than two copies.
C/C No copy of the version the research linked to PSAPL1 protein levels. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

PSAPL1 protein levels (rs73212548). MyGeneLog™. https://www.mygenelog.com/variants/rs73212548

← See all variants